Name Jintanat Ananworanich Current Position



Download 88.74 Kb.
Page4/5
Date31.01.2017
Size88.74 Kb.
#12880
1   2   3   4   5

Abstracts


  1. Ananworanich J, Gorowara M, Avihingsanon A, van Heesch N, Kerr SJ, Khongpetch C, Uanithirat A, Hill A, Ruxrungtham K, Burger D. Low dose raltegravir at 400mg once daily achieves adequate plasma concentrations in HIV-1 infected Thai patients [Abstract 649]. 18th Conference on Retroviruses and Opportunistic. February 27 –March 2, 2011, Boston

  2. Ananworanich J, Schuetz A, Sereti I, Rerknimitr R, deSouza M, Dewar R, Chomont N, Phanuphak N, Phanuphak P, Kim JH on behalf of the RV254/SEARCH 010 Study Group. Mega-HAART suppresses HIV viremia, reduces viral reservoir and restores immunity in peripheral blood and sigmoid colon of acute HIV-infected subjects [Abstract 516]. 18th Conference on Retroviruses and Opportunistic. February 27 –March 2, 2011, Boston

  3. Phanuphak N, Teeratakulpisarn N, van Griensven F, Chalermchai T, Chomchey N, Trichavaroj R, Rutvisuttinunt W, Paris R, Peel S and Ananworanich J on behalf of the RV254/SEARCH 010 Study Group. Relationship between ano-genital HIV RNA, sexual transmission routes, and acute HIV stages in acute HIV infected Thai subjects [Abstract 487]. 18th Conference on Retroviruses and Opportunistic. February 27 –March 2, 2011, Boston

  4. Valcour V, Sailasuta N, Chalermchai T, Marovich M, Lerdlum S, Sutticom D, Charnnarong N, Jagodzinski L, Michael N, Ananworanich J on behalf of the RV254/SEARCH 010 Study Group. HIV Brain Viral and Inflammatory Signature During Acute Infection [Abstract 54]. 18th Conference on Retroviruses and Opportunistic. February 27 –March 2, 2011, Boston

  5. Phanuphak N, Ananworanich J,  DeGruttola V, Jadwattanakul T, Valcour V, Gerschenson M, Shiramizu B, Kerr SJ, McArthur J, Shikuma C on behalf of the SEARCH 003 Study Group. Impact of Nucleoside Backbone and Predictors of Change over 24 Weeks in Distal Leg Epidermal Nerve Fiber Density following Initiation of Potent Antiretroviral Therapy [Abstract 419]. 18th Conference on Retroviruses and Opportunistic. February 27 –March 2, 2011, Boston

  6. Edwards-Jackson N, Phanuphak N, Van Tieu H, Chomchey N, Teeratakulpisarn N, Sathienthammawit W, Pakam C, Pharachetsakul N, Sobieszczyk M, Ananworanich J. HIV Serostatus Disclosure Does Not Predict Safer Sexual Behavior among HIV-Positive Men Who Have Sex with Men (MSM) in Bangkok, Thailand [Abstract 1039]. 18th Conference on Retroviruses and Opportunistic. February 27 –March 2, 2011, Boston

  7. Chokephaibulkit K, Prasitsuebsai W, Wittawatmongkol O, Gorowara M, Phongsamart W, Wongsabut J, Vanprapar N, Puthanakit T, Burger D, Ananworanich J on behalf of the HIV-NAT 113 Study Group. Pharmacokinetics of darunavir/ritonavir in Asian HIV-1 infected children aged ≥ 6 years [Abstract 714]. 18th Conference on Retroviruses and Opportunistic. February 27 –March 2, 2011, Boston

  8. Puthanakit T, Kerr S.J, Bunupuradah T, Aurpibul L, Taecharoenkul S, Sirisanthana V, Law M, Ananworanich J. Slow accumulation of thymidine analog and etravirine-associated mutations in NNRTI-treated children with virologic failure. 18th Conference on Retroviruses and Opportunistic [Abstract 720]. February 27 –March 2, 2011, Boston

  9. Soulas C, Autissier P, Schuetz A, Valcour V, Chalermchai T, Sithinamsuwan P, Rattanamanee S, Ananworanich J , Ratto-Kim S, Williams KC on behalf of the SEARCH007 Study Team. A Comprehensive Phenotypic Analysis of Monocyte Subsets: Modulation of Activation Markers and Chemokine Receptors in ART-Naïve HIV-1-Infected Individuals. 18th Conference on Retroviruses and Opportunistic. February 27 –March 2, 2011, Boston

  10. Avihingsanon A, Praditpornsilpa K, Wongsabut J, Clark A, Kerr SJ, Ubolyam S, Phanuphak P, Ananworanich J, Hiransuthikul N, Ruxrungtham K and HIV-NAT 006 study team. Prevalence and prognostic factors of chronic kidney disease in HIV-infected patients, HIV-NAT 006 cohort, Thailand [Abstract 843]. 18th Conference on Retroviruses and Opportunistic. February 27 –March 2, 2011, Boston

  11. Phanuphak N, Teeratakulpisarn N, Kerr SJ, Triratanachat S, Keelawat S, Pankam T, Sukjitpaiboonphol A, Phanuphak P, Ananworanich J, Palefsky J on behalf of the Thai Red Cross Men’s Sexual Health Clinic Team. High-grade anal intraepithelial neoplasia and high-risk human papillomavirus infection among HIV-positive and HIV-negative Thai men who have sex with men [Abstract 872]. 18th Conference on Retroviruses and Opportunistic. February 27 –March 2, 2011, Boston

  12. Klinklom A, Puthanakit T, Gorawara M, Phasomsap C, Sriheara C, Kerr SJ, Burger D, Ananworanich J, Pancharoen C, Ruxrungtham K. Low Dose Lopinavir/ritonavir Achieves Adequate Pharmacokinetic parameters in HIV-Infected Thai children [Abstract 709]. 18th Conference on Retroviruses and Opportunistic. February 27 –March 2, 2011, Boston

  13. Bunupuradah T, Boonyanurak P, Wilawan K, Loeanyod A, Saeloo S, Sophonphan J, Ananworanich J, Chaithongwongwatthana S. Age at menopause and menopausal-related symptoms in Thai HIV-infected women [P-34]. 1st International Workshop on HIV & Women, from adolescent through menopause. January 10-11, 2011, Washington D.C

  14. Edwards-Jackson NS, Kerr SJ, Van Tieu H, Ananworanich J, Hammer SM, Ruxrungtham K, Phanuphak P, Avihingsanon A and the HIV-NAT 006 Study Team. Cardiovascular Risk Assessment in Persons with HIV in the Developing World: Comparing Three Risk Equations in a Cohort of HIV-infected Thais. Tenth International Congress on Drug Therapy in HIV Infection. November 7-11, 2010 Glasgow

  15. Auchieng C, Ohata P, Ubolyam S, Lertarom P, Mengthaisong T, Laohajinda K, Kerr SJ, Suwanlerk T, Nanthapisal K, Janhom J, Ruengpanyathip C, Bunupuradah T, Avihingsanon A, Puthanakit T, Ruxrungtham K, Phanuphak P , Ananworanich J on behalf of the HIV-NAT study team. Assessment of study participants’ satisfaction of services provided by a clinical research organization in Bangkok [Abstract 619]. 2010 Australasian HIV/AIDS Conference [Abstract 746], October 20-22, 2010, Sydney

  16. Apornpong T, Avihingsanon A, Kerr SJ, Clarke A, Ananworanich J, Ruxrungtham K. Efficacy and safety of ATV/r 200/100mg (low dose). 2010 Australasian HIV/AIDS Conference [Abstract 746], October 20-22, 2010, Sydney

  17. Bunupuradah T, Ananworanich J, Chetchotisakd P, Kantipong P, Jirajariyavet S, Sirivichayakul S, Munsakul W, Prasithsirikul W, Sungkanuparph S, Bowonwattanuwong C, Klinbuayaem V, Chantbuddhiwet S, Chautrakarn S, Petoumenos K, Hirschel B, Bhakeecheep S, Ruxrungtham K on behalf of HIV STAR team. Prevalence and predictors of etravirine resistance in Thai HIV-infected adults failing first-line NNRTI-based regimens [MOPDB104]. XVIII International AIDS Conference, July 18-23, 2010, Vienna

  18. Bunupuradah T, Puthanakit T, Ananworanich J, Pancharoen C, Petoumenos K, Prasitsuebsai W, Wongngam W, Phanuphak P on behalf of study team. Immunogenicity and safety of intradermal compared to intramuscular hepatitis B vaccination in HIV-infected children [Abstract P17]. 2nd International Workshop on HIV Pediatrics, July 16-17, 2010, Vienna.

  19. Jaimulwong T, Ananworanich J, Bunupuradah T, Kosalaraksa P, Apornpong T, Hansudewechakul R, Hansudewechakul S, van der Lugt J, Vonthanak S, Shearer WT. Relationship between lymphocyte subsets and neurocognition in antiretroviral-naïve children with HIV infection [Abstract 795880]. Federation of Clinical Immunology Societies Conference, June 24-27, 2010, Boston.

  20. Pengnonyang S, Ananworanich J, Forrester J, Teeratakulpisarn N, Jadwattanakul T, Chomchey N, Siangphoe U, Wanke C, Phanuphak P, Phanuphak N. Validation of Anthropometry and BIA against DEXA for Body Composition Assessment in Antiretroviral-naïve HIV-infected Thai Patients. 17th Conference on Retroviruses and Opportunistic. February 16-19, 2010, San Francisco

  21. Avihingsanon A, Matthews G, Lewin S, Apornpong T, Duncombe C, Jupimai T, Ramautarsing R, Ananworanich J, Dore G, Ruxrungtham K. Tenofovir is Effective in Suppressing Hepatitis B viremia in HIV/HBV Coinfection Regardless of Previous Lamivudine/Emtricitabine Treatment. 17th Conference on Retroviruses and Opportunistic. February 16-19, 2010, San Francisco

  22. Shikuma C, Ananworanich J, Valcour V, Thomas A, DeGruttola V, McArthur J, Praihirunkit P, Hongchookiat P, Mathajittiphun P, Phanuphak P. Correlates of Epidermal Nerve Fiber Density in HIV-infected Individuals without Neuropathy prior to Initiation of Potent Antiretroviral Therapy. 17th Conference on Retroviruses and Opportunistic. February 16-19, 2010, San Francisco

  23. Kanjanavanit S, Puthanakit T, Kosalaraksa P, Hansudewechakul R , Ngampiyasakul C , Wongsawat J , Luesomboon W, Saphonn V, Ananworanich J, Ruxrungtham K and on behalf of the PREDICT study group. High prevalence of lipid abnormalities among HIV-infected children with mild to moderate immunosuppression in Thailand and Cambodia. 1st International Workshop on HIV Pediatrics, July 17-18, 2009, Cape Town

  24. Manosuthi W, Tieu HV, Mankatitham W, Lueangniyomkul A, Ananworanich J, Avihingsanon A, Siangphoe U, Klongugkara S, Thawornwan U, Suntisuklappon B, Sungkanuparph S, for the N2R Study Team. Clinical Case Definition and Manifestations of Paradoxical Tuberculosis (TB) Immune Reconstitution Inflammatory Syndrome (IRIS) [Abstract 911]. 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, July 19-22, 2009, Cape Town

  25. Bunupuradah T, Lumbiganon P, Puthanakit T, Ananworanich J, Mengthaisong T, Boonrak P, Phanuphak P, Burger D, Pancharoen C, Kosalaraksa P. Simplifying antiretroviral treatment in virally suppressed children by switching from double boosted protease inhibitors to lopinavir/ritonavir monotherapy [Abstract 1449]. 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, July 19-22, 2009, Cape Town [Also accepted as an oral presentation at the 1st International Workshop on HIV Pediatrics, July 17-18, 2009, Cape Town]

  26. Wongsawat J, Puthanakit T, Kanjanavanit S, Hansudewechakul R, Ngampiyasakul C, Kerr S, Ubolyam S, Suwanlerk T, Saphonn V, Ananworanich J. Sensitivity and Specificity of CD4 cell count to determine when to initiate ART according to the 2008 WHO guidelines [Abstract 1712]. 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, July 19-22, 2009, Cape Town [Also accepted as a poster presentation at the 1st International Workshop on HIV Pediatrics, July 17-18, 2009, Cape Town]

  27. Ananworanich J, Bunupuradah T, Ngampiyasakul C, Luesomboon W, Ubolyam S, Klangsinsirikul P, Gelman RS, Pattanapanyasat K, Saphonn V, Shearer WT, on behalf of the PREDICT study group. Peripheral blood T cell distributions in Thai and Cambodian children with HIV infection [Electronic Poster CDA 029]. 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, July 19-22, 2009, Cape Town [Also accepted as a poster presentation at the 1st International Workshop on HIV Pediatrics, July 17-18, 2009, Cape Town]

  28. Valcour V, Shiramizu B, Ananworanich J, Shikuma C. HIV DNA in circulating CD14+ cells correlates to dementia in HAART-naive subjects. 7th International Workshop on HIV Cells of Macrophage/Dendritic Lineage and Other Reservoirs. April 19-21, 2009, Colombaro di Corte Franca.

  29. van der Lugt J, Lange J, Avihingsanon A, Ananworanich J, Sealoo S, Burger D, Gorowara M, Phanuphak P, Ruxrungtham K. Bioavailability of generic lopinavir/ritonavir in HIV-1 infected individuals [Abstract P-01]. 10th International Workshop on Clinical Pharmacology of HIV Therapy, April 15-17, Amsterdam.

  30. van der Lugt J, Iulio J. di, Ananworanich J, Autar S, Ubolyam S, Siangphoe U, Jupimai T, Chetchotisakd P, Burger D, Ruxrungtham K, Hirschel B and the Staccato Thailand Study Group. Allelic variants of the CYP3A4 and 5, ABCB1 and SLCO1B1 Genes in a Thai HIV-infected Population on Saquinavir Based Antiretroviral Regimen. 10th International Workshop on Clinical Pharmacology of HIV Therapy, April 15-17, Amsterdam.

  31. van der Lugt J, Gorowara M, Avingsanon A, Sringam K, Wit F, Intasan J, Ananworanich J, Phanuphak P, Burger D, Ruxrungtham K. A Boosting-Dose of 50 milligram of Ritonavir Generates Adequate Saquinavir Plasma Concentrations in Thai HIV-infected Patients. 16th Conference on Retroviruses and Opportunistic. February 8-11, 2009, Montreal.

  32. Puthanakit T, Jourdain G, Santatiwong P, Chokephaibulkit K, Siangphoe U, Sirisanthana V, Kosalaraksa P, Petdachai W, Hansudewechakul R, Ananworanich J on behalf of the HIV-NAT 086 study team. Efficacy data on double ritonavir-boosted protease Inhibitor-based HAART regimens in 137 children who had experienced virological failure on NNRTI-based treatment. 16th Conference on Retroviruses and Opportunistic. February 8-11, 2009, Montreal.

  33. Li A, Phanuphak N, Sathianthammawit W, Avihingsanon A, Chaithongwongwatthana S, Teeratakupisarn N, van der Lugt J, Pankam T, Pakam C, Vermund S, Ruxrungtham K, Phanuphak P, Ananworanich J. HPV-associated anal disease in HIV-positive and HIV-negative men who have sex with men in Thailand. XVII International AIDS Conference, 3-8 August 2008, Mexico City

  34. Bunupuradah T, Suntarattiwong P, Sirivichayakul S, Li A, Pancharoen C, Boonrak P, Puthanakit T, Ruxrungtham K, Chotpitayasunondh T, Hirschel B, Ananworanich J and HIV-NAT 013 study team. Clinical, immunologic and virologic outcomes of genotyping directed second line therapy in Thai children who have failed dual NRTI Therapy. XVII International AIDS Conference, 3-8 August 2008, Mexico City

  35. Pengnonyang S, Phanuphak N, Justice A, Sadler S, Ananworanich J, Teeratakulpisarn S, Chaturawit C, Jantarapakde J, Winichagoon P, Gold J, Phanuphak P. Nutritional status of Thai HIV-infected orphans living in a family style community. XVII International AIDS Conference, 3-8 August 2008, Mexico City

  36. Tieu HV, Phanuphak N, Ananworanich J, Pharachetsakul N, Mingkwanrungrueng P, Buajoom R, Teeratakulpisarn S, Hammer S, Chiasson MA, Phanuphak P. Acceptability of Male Circumcision for Prevention of HIV among High-risk Heterosexual Men in Thailand XVII International AIDS Conference, 3-8 August 2008, Mexico City

  37. Ananworanich J, Phanuphak N, de Souza M, Paris R, Arroyo MA, Trichavaroj R, Sirivichayakul S, Pankam T, Shikuma C, Phanuphak P, Kim J. Incidence and Characterization of Anti-HIV Antibody Negative (Ab-), HIV Nucleic Acid Test Positive (NAT+) Acute HIV-1 Infections in a Thai High-Risk Cohort [Abstract 107]. HIV Pathogenesis March 27 - April 1, 2008, Banff

  38. Calmy A, Nguyen A, Montecucco F, Gayet-Ageron A, Burger F, Mach F, Carr A, Ubolyam S, Hirschel B and Ananworanich J for STACCATO study team. HIV activates markers of cardiovascular risk in a randomized scheduled-treatment interruption trial (STACCATO) [Abstract 140]. 15th Conference on Retroviruses and Opportunistic. February 3-6, 2008, Boston.

  39. Van Tieu H, Ananworanich J, Avihingsanon A, Apateerapong W, Sirivichayakul S, Klongutkara S, Boonchokchai B, Siangphoe U, Hammer S, Manosuthi W. Immunologic Markers as Predictors of Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome in HIV and TB Co-infected Persons in Thailand [Abstract 1008]. 15th Conference on Retroviruses and Opportunistic. February 3-6, 2008, Boston.

  40. Bunupuradah T, Kosalaraksa P, Engchanil C, Boonrak P, Hirunyanulux T, Ubolyam S, Lumbiganon P, Ruxrungtham K, Labriola-Tompkins E, Ananworanich J, and the HIV-NAT 017 Study Team. Efficacy and safety of double boosted SQV/LPV/r combination at 96 weeks in Thai children who have failed NRTI/NNRTI-based regimens [Abstract 586]. 15th Conference on Retroviruses and Opportunistic. February 3-6, 2008, Boston.

  41. van der Lugt J, Bunupuradah T, Kosalaraksa P, Puthanakit T, Engchanil C, Sakornjun W, Gorowara M, Ruxrungtham K, Burger D, Ananworanich J. Therapeutic Drug Monitoring of lopinavir and saquinavir in Thai HIV infected Children [Abstract 575]. 15th Conference on Retroviruses and Opportunistic. February 3-6, 2008, Boston.

  42. Valcour V, P Sithinamsuwan P, Pumpradit W, Ananworanich J, Nidhinandana S, Apateerapong W, Robertson K, Paul R, Siangphoe U, Shikuma C, and Southeast Asia Research Collaboration with Hawaii (SEARCH) 001 and 005 protocol teams. Intermediate (12 months) and Long-Term (6 years) Cognitive Response to HAART in Two Thai Cohorts [Abstract 387]. 15th Conference on Retroviruses and Opportunistic. February 3-6, 2008, Boston.

  43. Nüesch R, Ananworanich J, Srasuebkul P, Chetchotisakd P, Prasithsirikul W, Klinbuayam W, Mahanontharit A, Jupimai T, Ruxrungtham K, Hirschel B on behalf of the Staccato Hepatitis B Study Group. Interruptions of Tenofovir/Emtricitabine Based ART in Patients with HIV/HBV Co-Infection [3615]. 47th Interscience Conference on Antimicrobial and Chemotherapy. September 17-20, 2007, Chicago

  44. Ananworanich J, Bunupuradah T, Puthanakit T, Wongsawat J, Kanjanavanit S, Suwanalerk T, Sakornjun W, Ubolyam S, Pattanapanyasat K, Ruxrungtham K, Shearer W, on behalf of the PREDICT study group. Peripheral blood T cell distributions in Thai and Cambodian children with HIV infection. 4th IAS Conference on HIV Pathogenesis and Treatment. July 22-25, 2007, Sydney

  45. Butterworth O, Puthanakit T, Bunupuradah T, Mengthaisong T, Sakornjun W, Ananworanich J, Pancharoen C, Intasan J, Ruxrungtham K and the HIV-NAT Pediatric Study. HIV disclosure in Thai children. 4th IAS Conference on HIV Pathogenesis and Treatment. July 22-25, 2007, Sydney

  46. Bunupuradah T, Puthanakit T, Boonrak P, Butterworth O, Mengthaisong T, Intasan J, Ubolyam S, Kosalaraksa P, Engchanil C, Pagakrong Lumbiganond, Pancharoen C, Phanuphak P, Ananworanich J and the HIV-NAT Pediatric Study Team. Efficacy and safety of non nucleoside reverse transcriptase inhibitor (NNRTI) based highly active antiretroviral therapy (HAART) in Thai children with HIV. 4th IAS Conference on HIV Pathogenesis and Treatment. July 22-25, 2007, Sydney

  47. Puthanakit T, Kerr SJ, Ananworanich J, Bunupuradah T, Boonrak P, Butterworth O, Srisanthana V. Immunological Recovery in Children starting NNRTI-based HAART in a resource limited setting [Abstract 3476]. 4th IAS Conference on HIV Pathogenesis and Treatment. July 22-25, 2007, Sydney

  48. Kosalaraksa P, Engchanil C, Puthanakit T, Ananworanich J, Bunupuradah T, Luesomboon W, Vibol U, Sopa B, Intasan J, Jupimai T, Hirunwadee N, Waraporn S, Lumbiganon P, Ruxrungtham K, on behalf of the PREDICT study group [Abstract 2470]. 4th IAS Conference on HIV Pathogenesis and Treatment. July 22-25, 2007, Sydney

  49. Puthanakit T, Ananworanich J, Kosalaraksa P, Hansudewechakul R, Chuenyam T, Chettra K, Saphonn V, Chhi Vun M, Cooper D, Fox L, Ruxrungtham K, on behalf of the PREDICT study group. A randomized trial of early versus deferred initiation of antiretroviral therapy (ART) in HIV-infected children with moderate immune suppression in Cambodia and Thailand: The PREDICT study. 4th IAS Conference on HIV Pathogenesis and Treatment. July 22-25, 2007, Sydney

  50. Langford S, Gayet-Ageron G, Duncombe C, Jupimai T, Mahanontharit A, Kiatburanakul S, Munsakul W, Ruxrungtham K, Hirschel B, Ananworanich J and the Staccato Study Group. Supersensitive viral load assay to predict incomplete viral suppression during STI-re-treatment cycles [Abstract 5249]. 4th IAS Conference on HIV Pathogenesis and Treatment. July 22-25, 2007, Sydney

  51. Shiramizu B, Shikuma C, Ratto-Kim S, Ananworanich J, Valcour V. HIV-1-associated dementia associated with HIV DNA within monocytes in subjects treated or not treated with antiretroviral medications Infections [Abstract 114]. 14th Conference on Retroviruses and Opportunistic. February 25-28, 2007, Los Angeles.

  52. Ananworanich J, Gayet-Ageron A, Hirschel B, Lebraz M, Chetchotisakd P, Prasithsirikul W, Kiertiburanakul S, Munsakul W, Raksakulkarn P, Tansuphasawadikul S, Jupimai T, Ubolyam S, Schutz M, Ruxrungtham K, and the Staccato Study Group. Long-term efficacy and safety of once-daily ritonavir boosted-saquinavir mesylate (SQV/r) plus 2 NRTIs [Abstract WEPE0110]. XVI International AIDS Conference, August 13-19, 2006, Toronto

  53. Kosalaraksa P, Bunupuradah T, Engchanil C, Boonrak P, Intasan J, Ubolyam S, Pancharoen C, Lumbiganond P, Burger D, Ruxrungtham K, Schutz M, Ananworanich J, and the HIV-NAT 017 Study Team. Efficacy and Safety of Double boosted saquinavir (SQV)/lopinavir/ritonavir (LPV/r) in nucleoside pre-treated children at 48 weeks [Abstract MOPE0201]. XVI International AIDS Conference, August 13-19, 2006, Toronto

  54. Bunupuradah T, Kosalaraksa P Engchanil C, Sirivichayakul S, Intasan I.1, Ubolyam S, Pancharoen C, Lumbiganond P, Ruxrungtham K, Schutz M, Ananworanich J and the HIV-NAT 017 Study Team. Lack of PI resistance in children failing double boosted saquinavir (SQV)/ lopinavir/ ritonavir (LPV/r) combination. [Abstract MOPE0202]. XVI International AIDS Conference, August 13-19, 2006, Toronto

  55. Gayet-Ageron A, Ananworanich J, Jupimai T, Chetchotisakd P, Prasithsirikul W, Kiertiburanakul S, Munsakul W, Raksakulkarn P, Tansuphasawadikul S, Ubolyam S, Ruxrungtham K, Hirschel B and the Staccato Study Group [Abstract CDB0706]. No change in creatinine clearance after Tenofovir in Thai patients XVI International AIDS Conference, August 13-19, 2006, Toronto

  56. Mangclaviraj S, Chaitongwongwatana S, Kerr S, Ananworanich J, Hirschel B, Emery E, Cooper D, Kamemoto L, Ruxrungtham K, Phanuphak P. CD4 count and monthly income predict cervical squamous cell abnormalities in pap smear: results from the Women's Health Clinic at the Anonymous Clinic of the Thai Red Cross AIDS Research Centre [Abstract WEPE0247]. XVI International AIDS Conference, August 13-19, 2006, Toronto

  57. Lallemant M, Burger D, Lyall H, et al (Ananworanich J – in the PENTA 11 Study Group). Pharmacokinetics and virologic evaluation after stopping NNRTI in children: a substudy of the PENTA 11 (TICCH) trial [Abstract MOPE0206]. XVI International AIDS Conference, August 13-19, 2006, Toronto

  58. Ananworanich J, Gayet-Ageron A, LeBraz M, Furrer HJ, Prasithsirikul W, Chetchotisakd W, Kiertiburanakul S, Phanuphak P, Cooper DA, Ruxrungtham K, Hirschel B, and The Staccato Study Group. CD4-guided scheduled treatments interruptions (STIs) compared to continuous therapy (CT): Results of the Staccato trial [Abstract 102]. 13th Conference on Retroviruses and Opportunistic Infections, February 5-9, 2006, Denver

  59. Ananworanich J, Hirschel B, Furrer HJ, Ubolyam S, Gayet-Ageron A, Yerly S, Jupimai T, Hill A, Perrin L, Ruxrungtham K and The Staccato Study Group. CD4-guided Scheduled Treatment Interruptions: Low Incidence of Resistance Mutations in the Staccato Trial [Abstract 622B]. 13th Conference on Retroviruses and Opportunistic Infections, February 5-9, 2006, Denver

  60. Ananworanich J, Kosalaraksa P, Pancharoen C, Engchanil C, Pornprasit P, Apateerapong W, Ubolyam S, Intasan J, Lumbiganond P, Phanuphak P and the HIV-NAT 010 Study Team. Randomized Study of Immediate versus Deferred Highly Active Antiretroviral Therapy (HAART) in children [Abstract 701]. 13th Conference on Retroviruses and Opportunistic Infections, February 5-9, 2006, Denver

  61. Nuesch R, Srasuebkul P, Ananworanich J, Ruxrungtham K, Phanuphak P, Duncombe C and the HIV-NAT study team. Monitoring Toxicity of Antiretroviral Therapy in Resource limited Settings: a Prospective Clinical Trial Cohort in Thailand [Abstract 560b]. 13th Conference on Retroviruses and Opportunistic Infections, February 5-9, 2006, Denver


  62. Download 88.74 Kb.

    Share with your friends:
1   2   3   4   5



The database is protected by copyright ©ininet.org 2024
send message
    Main page
american academy